Delivery Order SPE2DB22D1106-SPE2DB24FESH6
- Not listed
- This federal contract award is for the delivery of TOPAMAX 50 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,069.49 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is issued under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is a delivery order worth $1,029 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TOPAMAX 50 MG TABLET 60S, a medication used to treat various medical conditions. The contract has an ultimate completion date of April 24, 2024 and is a firm fixed-price contract. The award is not associated with a specific set-aside program. AmerisourceBergen, as the prime contractor,...
- This federal contract award is for the delivery of TOPAMAX 50 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $21,372.07 firm fixed-price contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, on May 1, 2024, with a completion date of May 2, 2024. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TOPAMAX 50 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The total ceiling value of the contract is $1,114.44. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 18, 2024. The contract is not associated with any set-aside designation. Amerisourcebergen is a major supplier of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Topamax 50 mg tablets. The contract, valued at $2,058.00, is a Firm Fixed Price Delivery Order with a completion date of May 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,043.72 firm fixed-price delivery order is for the provision of TOPAMAX 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,867.80 firm fixed-price delivery order is for TOPAMAX 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical product TOPAMAX 50 MG TABLET 60S. The $1,029.00 contract is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for providing a...
- This federal contract award is for the delivery of Topamax 200 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,333.41 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 10, 2024 and was awarded on September 9, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) awarded a $12,893.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. This delivery order contract has an ultimate completion date of March 18, 2024 and was awarded on March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FESH6Delivery Order
This federal contract award is for the delivery of TOPAMAX 50 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $3,205.76. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 17, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award did not have a set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 5/16/24 |